The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2015

Filed:

Nov. 21, 2011
Applicants:

James Arnold, San Francisco, CA (US);

Todd Andrew Brugel, Wilmington, DE (US);

Scott Throner, Wilmington, DE (US);

Steven Wesolowski, Wilmington, DE (US);

Phil Edwards, Kennett Square, PA (US);

Andrew Griffin, Québec, CA;

Thierry Groblewski, Québec, CA;

Denis Labrecque, Québec, CA;

Inventors:

James Arnold, San Francisco, CA (US);

Todd Andrew Brugel, Wilmington, DE (US);

Scott Throner, Wilmington, DE (US);

Steven Wesolowski, Wilmington, DE (US);

Phil Edwards, Kennett Square, PA (US);

Andrew Griffin, Québec, CA;

Thierry Groblewski, Québec, CA;

Denis Labrecque, Québec, CA;

Assignee:

Astrazeneca AB, Södertälje, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 241/04 (2006.01); C07D 295/00 (2006.01); C07D 239/26 (2006.01); C07D 207/27 (2006.01); C07D 211/76 (2006.01); C07D 213/56 (2006.01); C07D 231/12 (2006.01); C07D 233/36 (2006.01); C07D 243/08 (2006.01); C07D 295/182 (2006.01); C07D 295/185 (2006.01); C07D 207/12 (2006.01); C07D 211/40 (2006.01); C07D 295/18 (2006.01);
U.S. Cl.
CPC ...
C07D 239/26 (2013.01); C07D 207/27 (2013.01); C07D 211/76 (2013.01); C07D 213/56 (2013.01); C07D 231/12 (2013.01); C07D 233/36 (2013.01); C07D 243/08 (2013.01); C07D 295/182 (2013.01); C07D 295/185 (2013.01); C07D 207/12 (2013.01); C07D 211/40 (2013.01); C07D 295/18 (2013.01);
Abstract

Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith.


Find Patent Forward Citations

Loading…